Adient ADNT 深 沪
已收盘 10-02 16:00:00 美东时间
17.31
-0.260
-1.48%
华盛通- 最 高17.83
- 今 开17.77
- 成交量 83.25万股
- 最 低 17.25
- 昨 收 17.57
- 总市值 13.35亿
- 52周最高 27.32
- 市盈率 静 --
- 换手率 1.08%
- 52周最低 16.51
- 委 比 50.00%
- 总股本 7709.69万
- 历史最高 85.165
- 量 比 0.75
- 振 幅 3.30%
- 历史最低 5.90
- 每 手 1
- 风险率 2.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adient Announces CFO Transition and Board Realignment
The latest update is out from Adient ( ($ADNT) ). Adient announced that board m...
09-18 19:15
Adient Appoints EVP And CFO, Effective November 16, Succeeding Mark Oswald
Adient (NYSE:ADNT), a global leader in automotive seating, today announced that on Oct. 1, 2026, Peter Carlin will be stepping down from Adient's board of directors and joining the company initially as vice president, finance. He will then be appointed executive vice president and chief financial of...
09-18 18:47
美股大行评级 | 巴克莱大幅升Strategy目标价至160美元！康宁遭看淡至180美元，较现价仍溢价25%
今日重点评级关注：HC Wainwright & Co.：上调Cardiff Oncology评级至"买入"，目标价9美元；古根海姆：维持Inventiva"买入"评级，目标价从11美元升至14美元
09-16 16:10
JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25
JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.
09-15 23:31
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21
Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.
08-18 21:50
Adient's Ana Romero-Davila is recognized as a Rising Star
PLYMOUTH, Mich., Aug. 17, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that Ana Romero-Davila, platform director at the company, has been ...
08-18 00:00
财报速睇 | Adient 2026财年Q2营收39.29亿美元，同比增长1.7%；归母净利润2.25亿美元，同比增长0.9%
华盛资讯8月13日讯，Adient公布2026财年Q2业绩，公司Q2营收39.29亿美元，同比增长1.7%，归母净利润2.25亿美元，同比增长0.9%。
08-13 19:03
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
